4
Changes in Ownership
ARROWHEAD PHARMACEUTICALS, INC. Filed Acc 0001628280-24-051924
Director sold 5,547 shares at an average $21.91 ($121,556)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| GIVEN DOUGLAS B Director | 2024-12-16 | Sale 10b5-1 | −5,000 | $21.90 | $109,500 | 124,714 | D |
| GIVEN DOUGLAS B Director | 2024-12-17 | Sale 10b5-1 | −547 | $22.04 | $12,056 | 124,167 | D |
| Open-market sales · 5,547 sh · avg $21.91 · $121,556 | |||||||
Loading xslF345X05/wk-form4_1734563922.xml…